SCHEMBL13699828

SCHEMBL13699828

NC(=O)c1oc2cc(Cl)ccc2c1NC(=O)c1ccc(-c2ccccc2)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 7/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPK10 P53779 3/20 0.49
HSD17B10 Q99714 3/20 0.49
TP53 P04637 2/20 0.49
KDM4E B2RXH2 2/20 0.48
HPGD P15428 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
TSHR P16473 2/20 0.47
KCNH2 Q12809 1/20 0.45
NPC1 O15118 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
S1PR2 O95136 2/20 0.44
S1PR3 Q99500 2/20 0.44
S1PR5 Q9H228 2/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
MAPT P10636 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13700073 0.85 KCNH2 (0.56) S1PR4MEN1KMT2AALDH1A1TP53
SCHEMBL4254377 0.85 HSD17B10 (0.60) S1PR4MEN1KMT2AALDH1A1MAPK10
SCHEMBL13700071 0.85 S1PR4 (0.62) S1PR4MEN1KMT2AALDH1A1HSD17B10
SCHEMBL13699818 0.82 KDM4E (0.55) S1PR4MEN1KMT2AALDH1A1MAPK10
SCHEMBL13699827 0.81 TP53 (0.55) S1PR4MEN1KMT2AALDH1A1MAPK10
SCHEMBL13700051 0.81 KDM4E (0.50) S1PR4MEN1KMT2AALDH1A1MAPK10
SCHEMBL13699822 0.80 KDM4E (0.52) S1PR4MEN1KMT2AALDH1A1MAPK10
SCHEMBL13700067 0.79 KDM4E (0.52) S1PR4MEN1KMT2AALDH1A1MAPK10
SCHEMBL13700066 0.79 S1PR4 (0.57) S1PR4MEN1KMT2AALDH1A1MAPK10
SCHEMBL13700304 0.79 MAPK10 (0.45) MEN1KMT2AALDH1A1MAPK10HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F S1PR4 1983/4885MEN1 4409/4885KMT2A 2861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.